Sort
130,381 grants matching “hiv”
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
$907,386Michael David Alpert · Emmune, Inc · R44 · FY2022 · AI
NATIONAL NEUROLOGICAL AIDS BANK
$907,330University Of California Los Angeles · R24 · FY2001 · NS
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$907,297Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles
$907,275Rui Kong · Emory University · R01 · FY2022 · AI
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles
$907,227Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2023 · AI
TICIPS: HIV/AIDS, Secondary Infections and Immune Modul*
$907,207University Of Missouri-Columbia · U19 · FY2005 · AT
Vascular macrophages and T cells in atherosclerosis
$907,152Klaus F. Ley · La Jolla Institute For Immunology · R35 · FY2021 · HL
Integrating HCV services into HIV programs for PWID in India
$907,120Shruti H Mehta · Johns Hopkins University · R01 · FY2023 · AI
Suubi4Her: A Combination Intervention Addressing HIV Risk Behaviors Among Older Adolescent Girls Transitioning into Adulthood in Uganda
$907,118Fred M Ssewamala · Washington University · R01 · FY2020 · MH
Clinical Trials Engine Lentiviral engineered T cells for HIV
$907,100Carl H. June · University Of Pennsylvania · U19 · FY2007 · AI
Modulating mucosal DCs and T cells to limit SIV spread
$907,071Melissa J Robbiani · Population Council · R37 · FY2012 · AI
Modulating mucosal DCs and T cells to limit SIV spread
$907,071Nina R. Derby · Population Council · R01 · FY2014 · AI
Vascular macrophages and T cells in atherosclerosis
$906,991Klaus F. Ley · La Jolla Institute For Immunology · R35 · FY2020 · HL
NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans
$906,964Ruy M Ribeiro · Triad National Security, Llc · R01 · FY2023 · AI
Reconstructing HIV Epidemics from HIV Phylogenetics
$906,886Thomas K. Leitner · Triad National Security, Llc · R01 · FY2020 · AI
A unified intervention for young gay and bisexual men's minority stress, mental health, and HIV risk
$906,854John Edward Pachankis · Yale University · R01 · FY2018 · MH
Focal Segmental Glomerulosclerosis: Genetics & Mechanisms
$906,806Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Focal Segmental Glomerulosclerosis: Genetics & Mechanisms
$906,806Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Focal Segmental Glomerulosclerosis: Genetics & Mechanisms
$906,806Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Focal Segmental Glomerulosclerosis: Genetics & Mechanisms
$906,806Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
HIV RNase H natural product inhibitors
$906,793Michael A Parniak · University Of Pittsburgh At Pittsburgh · U19 · FY2010 · AI
PEDIATRIC AIDS CLINICAL TRIALS GROUP
$906,730University Of California San Diego · U01 · FY2000 · AI
Optimizing AAV delivery of bNAbs for HIV prevention
$906,720Matthew Ryan Gardner · Emory University · R01 · FY2022 · AI
Fusion peptide directed immunogens that elicit neutralizing and protective antibodies in non-human primates
$906,668Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2022 · AI
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics
$906,620Christine Cheng · Boston University (Charles River Campus) · R33 · FY2022 · DA